DoctorDirectory.ai
Menu

Dr. Robert Rosenson, MD

Not yet claimed

Cardiologist, Preventive cardiologist, Lipidologist · Physician (MD)

New York, NY

Not yet claimed. This listing was researched from public sources and screened against our eligibility rules, but the provider has not yet claimed it, verified the details, or attested to guideline-based care. Are you Robert Rosenson? Claim this profile.

Dr. Robert Rosenson is a cardiologist in New York City associated with Mount Sinai who works in the area of cholesterol and lipid disorders. It is not yet confirmed whether he sees patients in an outpatient clinic.

About Dr. Robert Rosenson, MD

Updated Sep 20, 2026 · next review Dec 19, 2026

Dr. Robert S. Rosenson is a cardiologist in New York City who focuses on preventive cardiology and lipid (cholesterol) disorders. He practices at The Mount Sinai Hospital at 5 E 98th St and is board certified in internal medicine with a subspecialty in cardiovascular disease.

At Mount Sinai he holds the title of Dr. Rony Shimony Distinguished Professor of Cardiovascular Medicine and serves as System Director of Metabolism and Lipids, and he directs the Metabolism and Lipids Program at the Icahn School of Medicine. He trained at Tulane University School of Medicine, did his internal medicine residency at Brigham and Women's Hospital, and completed a cardiovascular medicine fellowship at the University of Chicago plus an extra research year in lipoprotein metabolism.

Much of his public work involves cholesterol research and guidance. He has published on olpasiran, an experimental drug that lowers lipoprotein(a), a high-risk type of cholesterol, and he chaired the Statin Safety Expert Muscle Document Committee. He is also a national board member of the National Lipid Association and Co-Editor-in-Chief of the journal Cardiovascular Drugs and Therapy.

Public listings show he sees outpatients through Mount Sinai Doctors and is listed as accepting new patients and telehealth appointments.

Board certification
Diplomate of the American Board of Internal Medicine with subspecialty certification in cardiovascular disease, and a diplomate of the National Lipid Association. profiles.mountsinai.org
Mount Sinai leadership roles
He is the Dr. Rony Shimony Distinguished Professor of Cardiovascular Medicine and System Director of Metabolism and Lipids at Mount Sinai Health System. profiles.mountsinai.org
Training background
Medical degree from Tulane University School of Medicine, internal medicine residency at Brigham and Women's Hospital, and cardiovascular fellowship at the University of Chicago with an added research year in lipoprotein metabolism. profiles.mountsinai.org
Statin safety committee chair
He served as Chair of the Statin Safety Expert Muscle Document Committee and has served on nine American College of Cardiology committees. profiles.mountsinai.org
Lipoprotein(a) research
He was first author on a May 2025 JAMA Cardiology analysis from the OCEAN(a)-DOSE trial of olpasiran, looking at oxidized phospholipids and inflammatory markers. pubmed.ncbi.nlm.nih.gov
Cholesterol-lowering trial finding
A Mount Sinai newsroom item from February 2025 described his analysis showing that higher doses of olpasiran lowered lipoprotein(a) by more than 95% in patients with atherosclerotic cardiovascular disease. mountsinai.org
National Lipid Association award
He received the Foundation of the National Lipid Association 2019 Clinician/Educator Award. mountsinai.org
Journal editor
He is Co-Editor-in-Chief of the journal Cardiovascular Drugs and Therapy. zocdoc.com
Society fellowships
He is a fellow of the American College of Cardiology, American College of Physicians, American Heart Association, European Society of Cardiology, and the National Lipid Association. profiles.mountsinai.org
Seeing new patients
Directory listings show an outpatient practice through Mount Sinai Doctors in Manhattan, with new patient and telehealth appointments listed as available. healthgrades.com

Worth knowing

  • CMS Open Payments records for 2021-2025 list $117,405.85 across 131 records, with the largest amounts from Amgen ($30,624.42), Regeneron ($27,702.31), Eli Lilly ($15,330.15), Mylan ($15,254.91) and AstraZeneca UK ($7,811.72). Payments from industry to physicians are common and legal, and are publicly reported. openpaymentsdata.cms.gov
  • In his own published disclosures he reports institutional research grants from Amgen, Arrowhead, Lilly, Novartis and Regeneron; consulting fees from several of those companies plus CRISPR Therapeutics, Precision Biosciences and Ultragenyx; non-promotional speaker fees from Amgen and Kowa; and stock in MediMergent. Several of these companies make or develop cholesterol-related drugs he studies. jacc.org
  • A Wikipedia entry about him lists education details that conflict with his Mount Sinai faculty profile, so details from that page should be treated as unverified. en.wikipedia.org

Industry payments (CMS Open Payments)

Open the CMS record

Federal law requires drug and device companies to report what they pay clinicians: meals, travel, speaking, consulting, and research. Payments are common and legal; the point is that you can see them.

2021 to 2025

$117,406

131 payments

2021$6,174
2022$23,987
2023$26,186
2024$50,342
2025$10,717

Top payers

  • Amgen Inc.$30,624
  • Regeneron Pharmaceuticals, Inc.$27,702
  • Eli Lilly and Company$15,330
  • Mylan Inc.$15,255
  • AstraZeneca UK Limited$7,812

Payment types

  • Consulting Fee$80,206
  • Travel and Lodging$21,577
  • Compensation for serving as faculty or as a speaker for a medical education program$6,750
  • Food and Beverage$3,864
  • Honoraria$3,098

A word of caution about these numbers

A payment does not mean your doctor is compromised or acting unethically. Most of these entries are drug samples left for patients, or lunch brought in for the office staff, and the amounts are usually small. Research funding and speaking at medical meetings are also normal parts of a clinical career.

As a rough guide, a total under $15,000 a year is usually not a concern. Much larger sums, especially from one company whose product your doctor recommends to you, are worth asking about. You are allowed to ask.

Sources: npino.com · topnpi.com · profiles.mountsinai.org · icahn.mssm.edu · linkedin.com · twitter.com · zocdoc.com · healthgrades.com. Something wrong or out of date? Tell us and we will correct it.

Summary prepared with AI assistance from the public sources linked above, reviewed every three months. It is not a review, a rating, or an endorsement.

Practice location

Something wrong with this profile? ·